Intarcia is committed to establishing and maintaining mature, respectful relationships with our stakeholders. We have a profound sense of accountability for the timely release of information, to be responsive to reasonable requests, and to assure the authority and accuracy of the information we provide. We look forward to engaging with our investors, the trade and consumer media, and our business partners and other stakeholders.
|
March 21, 2013 Intarcia Enrolls First Patients in "Freedom" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes |
June 13, 2013
February 5, 2013
Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
November 15, 2012
October 03, 2012
April 02, 2012
March 27, 2012
Intarcia Appoints Michelle Baron, MD, FACE, Vice President and Chief Medical Officer
December 13, 2011
James Ahlers
james.ahlers@intarcia.com
(510) 782-7800 (office)